PSMAfore: Control Arm and Sequencing Considerations

In a follow-up conversation, Christopher Wallis, MD, PhD, FRCSC, University of Toronto, and Oliver Sartor, MD, Mayo Clinic, highlight potential issues with the control arm as well as considerations for treatment sequencing that came out of the PSMAfore trial.

Results of this study were presented by Dr. Sartor as a late-breaking abstract at the ESMO Congress 2023.

View his previous comments on PSMAfore Methodology, Nuances, and Implications.